Haemonetics HAE Institutional Ownership

Updated Oct 11, 2026

Haemonetics Corp (NYSE:HAE) appeared in the 13F filings of 328 institutional investors for the quarter ended June 30, 2026.

• Total holdings of Haemonetics shares rose 4.77% from Q1 2026, and the number of holders rose 11.19% from Q2 2025.
• Among the 328 holders of Haemonetics, 164 added to their positions, 118 reduced their stakes and 46 left their positions unchanged.
• Combined, institutional investors held 49.62Mn shares of HAE as of Q2 2026, up 2.26Mn from the prior quarter and down 3.88Mn from a year earlier.
• BlackRock, Inc. held the largest position in HAE at 5.91Mn shares as of June 30, 2026.
• The largest position increases in HAE for Q2 2026 were by Citadel Advisors LLC (+1.25Mn shares), Neuberger Berman Group LLC (+618.52K shares), Millennium Management LLC (+560.63K shares), Holocene Advisors, LP (+545.67K shares) and T. Rowe Price Investment Management, Inc. (+504.22K shares).
• Among holders that kept a stake in Haemonetics, the biggest sellers in Q2 2026 were AQR Capital Management LLC (-1.09Mn shares), FMR LLC (-987.83K shares), North Peak Capital Management, LLC (-655.88K shares), Invenomic Capital Management LP (-448.51K shares) and Qube Research & Technologies Ltd (-384.48K shares).
• Business Quant data shows the 10 biggest positions in Haemonetics as of Q2 2026 were held by BlackRock, Inc. (5.91Mn shares), Neuberger Berman Group LLC (4.18Mn shares), Vanguard Portfolio Management LLC (2.55Mn shares), AQR Capital Management LLC (2.27Mn shares), Ariel Investments, LLC (2.06Mn shares), Vanguard Capital Management LLC (2.06Mn shares), State Street Corp (1.82Mn shares), Dimensional Fund Advisors LP (1.59Mn shares), Citadel Advisors LLC (1.51Mn shares) and Geode Capital Management, LLC (1.29Mn shares).